BLS Pharmaceuticals (FRA:PR80) Change In Inventory: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PR80 BLS Pharmaceuticals Ltd FRA:PR80
38 GF Score
Price €0.58
GF Value €0.41
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is BLS Pharmaceuticals Change In Inventory?

BLS Pharmaceuticals FRA:PR80 +6.68% 38 Change In Inventory is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:PR80 with a GF Score™ of 38/100 and a GF Value™ of €0.41 (Significantly Overvalued). The stock has 8 warning signs investors should review.

BLS Pharmaceuticals's change in inventory for the quarter that ended in Dec. 2025 was €0.00 Mil. It means BLS Pharmaceuticals's inventory stayed the same from Jun. 2025 to Dec. 2025 .

BLS Pharmaceuticals's change in inventory for the fiscal year that ended in Jun. 2025 was €0.00 Mil. It means BLS Pharmaceuticals's inventory stayed the same from Jun. 2024 to Jun. 2025 .

BLS Pharmaceuticals's Total Inventories for the quarter that ended in Dec. 2025 was €6.66 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BLS Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2025 was 107.67.

Inventory Turnover measures how fast the company turns over its inventory within a year. BLS Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.69.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BLS Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.24.

BLS Pharmaceuticals  (FRA:PR80) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BLS Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=4.3465/7.367*365 / 2
=107.67

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BLS Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=7.367 / 4.3465
=1.69

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BLS Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=4.3465 / 17.767
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BLS Pharmaceuticals Change In Inventory Related Terms

BLS Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for BLS Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BLS Pharmaceuticals Change In Inventory Chart

BLS Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BLS Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:PR80
38GF Score
BLS Pharmaceuticals Ltd FRA:PR80
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BLS Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €0.00 Mil mean?
BLS Pharmaceuticals (FRA:PR80) has a Change In Inventory of €0.00 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for BLS Pharmaceuticals and its competitors.
Is BLS Pharmaceuticals' Change In Inventory too high?
BLS Pharmaceuticals' current Change In Inventory is €0.00 Mil. Overall, BLS Pharmaceuticals has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BLS Pharmaceuticals' Change In Inventory compare to ?
BLS Pharmaceuticals' Change In Inventory of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for BLS Pharmaceuticals and its competitors. BLS Pharmaceuticals's current Change In Inventory is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLS Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, BLS Pharmaceuticals (FRA:PR80) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.41, compared to a current price of €0.58 — trading 41% above its estimated fair value. The current Change In Inventory is €0.00 Mil. BLS Pharmaceuticals' overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For BLS Pharmaceuticals (FRA:PR80), the current Change In Inventory is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BLS Pharmaceuticals (FRA:PR80) Overvalued in 2026?

Based on GuruFocus' analysis, BLS Pharmaceuticals stock appears to be overvalued. The current stock price of €0.58 is trading 41% above its estimated GF Value™ of €0.41. GuruFocus considers BLS Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for FRA:PR80:

  • Change In Inventory: €0.00 Mil
  • GF Value™: €0.41 vs. price of €0.58 (41% above fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the FRA:PR80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BLS Pharmaceuticals Business Description

Comparable Companies
Other Exchanges BLS:Australia
Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments, namely, Pharmaceutical manufacture and wholesale supply (business to business), Manufacture and distribution (wholesale, online, and retail), and Wholesale of patented Probiotics.
38GF Score

Get the complete analysis for FRA:PR80

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.58
Price
€0.41
GF Value